All Stories

  1. Fomite Persistence of the Porcine Reproductive and Respiratory Syndrome Virus is Affected by Relative Humidity and Storage Temperature
  2. Lipid nanoparticle-encapsulated DNA vaccine induces balanced antibody and T-cell responses in pigs with maternally derived antibodies
  3. Lipid nanoparticle-encapsulated DNA vaccine encoding African swine fever virus p54 antigen elicits robust immune responses in pigs
  4. Modification of the splice acceptor in CD163 exon 7 of pigs is insufficient to confer resistance to PRRSV
  5. New insights into the testicular tropism of porcine reproductive and respiratory syndrome virus
  6. African swine fever viral proteins that inhibit cGAS-STING pathway and type-I interferon production
  7. Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses
  8. Evaluation of the diagnostic sensitivity and specificity of two pen-side tests for detecting African swine fever virus in experimentally infected pigs
  9. African swine fever virus early protein pI73R suppresses the type-I IFN promoter activities
  10. Recent progress on gene-deleted live-attenuated African swine fever virus vaccines
  11. Assessment of Immune Responses to a Trivalent Pichinde Virus-Vectored Vaccine Expressing Hemagglutinin Genes from Three Co-Circulating Influenza A Virus Subtypes in Pigs
  12. Functional and evolutionary analysis of host Synaptogyrin-2 in porcine circovirus type 2 susceptibility
  13. Comparative Analysis of Swine Antibody Responses following Vaccination with Live-Attenuated and Killed African Swine Fever Virus Vaccines
  14. A Single-Dose Intramuscular Immunization of Pigs with Lipid Nanoparticle DNA Vaccines Based on the Hemagglutinin Antigen Confers Complete Protection against Challenge Infection with the Homologous Influenza Virus Strain
  15. A Single Amino Acid Substitution in Porcine Reproductive and Respiratory Syndrome Virus Glycoprotein 2 Significantly Impairs Its Infectivity in Macrophages
  16. Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
  17. A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis
  18. Identification of Cryptic Promoter Activity in cDNA Sequences Corresponding to PRRSV 5′ Untranslated Region and Transcription Regulatory Sequences
  19. Differential antibody responses in sows and finishing pigs naturally infected with African swine fever virus under field conditions
  20. Porcine Reproductive and Respiratory Syndrome Virus Infection Upregulates Negative Immune Regulators and T-Cell Exhaustion Markers
  21. Porcine Reproductive and Respiratory Syndrome Virus Reverse Genetics and the Major Applications
  22. Evaluation of Antibody Response Directed against Porcine Reproductive and Respiratory Syndrome Virus Structural Proteins
  23. Host Transcriptional Response to Persistent Infection with a Live-Attenuated Porcine Reproductive and Respiratory Syndrome Virus Strain
  24. Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine
  25. Synaptogyrin-2 influences replication of Porcine circovirus 2
  26. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening
  27. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus
  28. Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and Defective in Neuroinvasion
  29. Relative contribution of porcine reproductive and respiratory syndrome virus open reading frames 2–4 to the induction of protective immunity
  30. Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus
  31. Identification of viral genes associated with the interferon-inducing phenotype of a synthetic porcine reproductive and respiratory syndrome virus strain
  32. Complete Genome Sequence of Highly Virulent Porcine Reproductive and Respiratory Syndrome Virus Variants That Recently Emerged in the United States: TABLE 1 
  33. A Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain Confers Unprecedented Levels of Heterologous Protection
  34. Mutations in the 5’ NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity
  35. Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus
  36. Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1
  37. Immune Evasion of Porcine Reproductive and Respiratory Syndrome Virus through Glycan Shielding Involves both Glycoprotein 5 as Well as Glycoprotein 3
  38. Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response